Atlas Trials

Feasibility and Efficacy Study of Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation (HCT) With Fludarabine, Busulfan, and Total Body Irradiation (TBI)

Clinical trial NCT00815568 · UNKNOWN

Trial details

NCT number
NCT00815568
Sponsor
Samsung Medical Center
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
AMLMDSALLCMLLymphoma
Start date
2008-08-01
Primary completion
2011-12-01
Enrollment
114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.